Patch Technologies

Patch Biosciences is a biotechnology company focused on the design of synthetic DNA sequences to enhance the safety and efficacy of genetic medicines. The company utilizes a proprietary AI-driven platform and high-throughput screening to engineer regulatory elements, such as promoters and enhancers, that provide precise control over gene expression. By optimizing these sequences, Patch Biosciences aims to overcome current limitations in gene therapy, including toxicity and insufficient expression levels. The company's technology is applicable across various modalities, including viral gene therapy and mRNA-based therapeutics, targeting a broad range of genetic and rare diseases.